Growth Metrics

bioAffinity Technologies (BIAF) Total Liabilities (2022 - 2025)

Historic Total Liabilities for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $2.6 million.

  • bioAffinity Technologies' Total Liabilities fell 2293.27% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 2293.27%. This contributed to the annual value of $3.9 million for FY2024, which is 1619.98% up from last year.
  • Per bioAffinity Technologies' latest filing, its Total Liabilities stood at $2.6 million for Q3 2025, which was down 2293.27% from $6.9 million recorded in Q2 2025.
  • bioAffinity Technologies' Total Liabilities' 5-year high stood at $6.9 million during Q2 2025, with a 5-year trough of $775151.0 in Q2 2023.
  • Over the past 4 years, bioAffinity Technologies' median Total Liabilities value was $3.2 million (recorded in 2023), while the average stood at $2.9 million.
  • In the last 5 years, bioAffinity Technologies' Total Liabilities skyrocketed by 31583.3% in 2024 and then plummeted by 2293.27% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Total Liabilities stood at $1.1 million in 2022, then soared by 195.63% to $3.4 million in 2023, then grew by 16.2% to $3.9 million in 2024, then crashed by 32.4% to $2.6 million in 2025.
  • Its Total Liabilities was $2.6 million in Q3 2025, compared to $6.9 million in Q2 2025 and $4.1 million in Q1 2025.